Cargando…

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

BACKGROUND: Deletions of 17p13 recurrently occur in renal cell carcinoma (RCC) but their prognostic role seems to be uncertain. METHODS: To determine prevalence, relationship with tumor phenotype, and patient prognosis, a tissue microarray containing samples from 1809 RCCs was evaluated using dual l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichenauer, Till, Shadanpour, Navid, Kluth, Martina, Göbel, Cosima, Weidemann, Sören, Fraune, Christoph, Büscheck, Franziska, Hube-Magg, Claudia, Möller-Koop, Christina, Dahlem, Roland, Fisch, Margit, Rink, Michael, Riechardt, Silke, Burandt, Eike, Bernreuther, Christian, Minner, Sarah, Simon, Ronald, Sauter, Guido, Wilczak, Waldemar, Clauditz, Till
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293794/ https://www.ncbi.nlm.nih.gov/pubmed/32534597 http://dx.doi.org/10.1186/s12957-020-01902-y

Ejemplares similares

High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma
por: Eichenauer, Till, et al.
Publicado: (2020)

Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes
por: Büscheck, Franziska, et al.
Publicado: (2020)

p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors
por: Steurer, Stefan, et al.
Publicado: (2021)

Y-chromosome loss is frequent in male renal tumors
por: Büscheck, Franziska, et al.
Publicado: (2021)

Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
por: Möller, Katharina, et al.
Publicado: (2021)

A non-diploid DNA status is linked to poor prognosis in renal cell cancer
por: Büscheck, Franziska, et al.
Publicado: (2020)

Napsin A Expression in Human Tumors and Normal Tissues
por: Weidemann, Sören, et al.
Publicado: (2021)

Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors
por: Menz, Anne, et al.
Publicado: (2021)

Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular Carcinoma
por: Lennartz, Maximilian, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours
por: Meiners, Jan, et al.
Publicado: (2021)

E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors
por: Burandt, Eike, et al.
Publicado: (2021)

MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples
por: Rico, Sebastian Dwertmann, et al.
Publicado: (2021)

Mismatch repair deficiency occurs very rarely in seminomas
por: Dum, David, et al.
Publicado: (2021)

Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors
por: Reiswich, Viktor, et al.
Publicado: (2021)

Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications
por: Völkel, Cosima, et al.
Publicado: (2021)

Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas
por: Fraune, Christoph, et al.
Publicado: (2020)

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer
por: Eichenauer, Till, et al.
Publicado: (2019)

Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas
por: Uhlig, Ria, et al.
Publicado: (2022)

Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors
por: Dum, David, et al.
Publicado: (2022)

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers
por: Möller, Katharina, et al.
Publicado: (2020)

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues
por: Kind, Simon, et al.
Publicado: (2019)

High prevalence of p16 staining in malignant tumors
por: De Wispelaere, Noémi, et al.
Publicado: (2022)

High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer
por: Weidemann, Sören, et al.
Publicado: (2023)

Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells
por: Lennartz, Maximilian, et al.
Publicado: (2022)

DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness
por: Jansen, Kristina, et al.
Publicado: (2021)

Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland
por: Gorbokon, Natalia, et al.
Publicado: (2023)

Prevalence of CD8(+) cytotoxic lymphocytes in human neoplasms
por: Blessin, Niclas C., et al.
Publicado: (2020)

Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer
por: Marx, Andreas, et al.
Publicado: (2021)

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer
por: Weidemann, Sören A., et al.
Publicado: (2019)

Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors
por: Weidemann, Sören, et al.
Publicado: (2021)

Deletion of 18q is a strong and independent prognostic feature in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2016)

MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes
por: Fraune, Christoph, et al.
Publicado: (2020)

Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes
por: Fraune, Christoph, et al.
Publicado: (2022)

Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors
por: Weidemann, Sören, et al.
Publicado: (2022)

SNW1 is a prognostic biomarker in prostate cancer
por: Höflmayer, Doris, et al.
Publicado: (2019)

Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors
por: Menz, Anne, et al.
Publicado: (2022)

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues
por: Bonk, Sarah, et al.
Publicado: (2019)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas
por: Uhlig, Ria, et al.
Publicado: (2023)

Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors
por: Viehweger, Florian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n26arurmgl9f3jhr8h6t3h075q